BioCentury | Apr 13, 2018
Targets & Mechanisms

Hello RNA

BioCentury’s analysis of new and emerging targets presented at this year’s AACR meeting reveals a surge in activity in non-coding RNAs, as researchers continue to expand target space. The results also reflect the ongoing high...
BioCentury | Mar 28, 2018
Distillery Techniques


...expression levels of 32 of the genes, including centromere protein E (CENPE), cofilin 1 (CFL1), cell division cycle associated 7 (CDCA7)...
...Haider, The Institute of Cancer Research, London, U.K. email: Elizabeth S. Eaton The Institute of Cancer Research Cell division cycle associated 7 (CDCA7) Centromere...
BioCentury | Sep 10, 2015
Distillery Techniques

Techniques: Loss-of-function mutations in cell division cycle associated 7 (CDCA7) and helicase lymphoid specific (HELLS) as diagnostic markers for immunodefici

Biomarkers CDCA7 HELLS cell division cycle associated 7 (CDCA7) helicase lymphoid specific (HELLS) Leiden University Medical Center BC Staff...
BioCentury | Jan 20, 2014
Product Development

Next in NASH

Intercept Pharmaceuticals Inc. will need to resolve at least three things before its obeticholic acid can be approved and widely adopted for NASH. The company must settle on a Phase III trial design and address...
Items per page:
1 - 4 of 4